SHPA has called for both wider access to oral COVID-19 antivirals to combat rising COVID-19 hospitalisations amid a constrained hospital workforce, and an additional vaccine booster for healthcare workers for their protection.
SHPA has welcomed yesterday’s announcement by the Federal Minister for Health and Aged Care, the Hon. Greg Hunt MP on the listing of molnupiravir (Lagevrio) on the Pharmaceutical Benefits Scheme (PBS).
Leading Hospital Pharmacists call for a consistent, streamlined approach to support the safe prescribing + dispensing of novel oral COVID-19 treatments in clinical care nirmatrelvir/ritonavir (Paxlovid) and molnupiravir (Lagevrio).
SHPA has reiterated the urgent need for Rapid Antigen Tests (RATs) to be made available to Hospital Pharmacists and their colleagues, as steeply rising numbers of positive COVID-19 cases and healthcare workers in isolation puts hospitals under intense pressure.
SHPA has called for COVID-19 rapid antigen tests to be made freely available as supply increases over January, as stress on hospital capacity and strain on Hospital Pharmacists and their peers grows due to surging infections.
The Society of Hospital Pharmacists of Australia (SHPA) has welcomed Prime Minister Scott Morrison’s announcements yesterday on Australia’s COVID-19 vaccine booster program following the emergency meeting of the National Cabinet.
The Society of Hospital Pharmacists of Australia (SHPA) has welcomed the seventh consecutive fastest million COVID-19 vaccine doses in state and territory clinics – administered in just 11 days – with Sunday’s figures confirming the seven million dose milestone as the rollout total exceeds 17 million doses nationwide.
SHPA has welcomed the fastest million COVID-19 vaccine doses in state and territory clinics to date – administered in just a fortnight – with today’s figures confirming six million doses have now been administered by these clinics, contributing to the total of more than 14 million doses nationwide.
